Question 1

What is Neurocrine Biosciences Inc's WACC?

Accepted Answer

Neurocrine Biosciences Inc (NBIX) has a Weighted Average Cost of Capital (WACC) of 6.80%. This is calculated using a Cost of Equity of 6.80% (via CAPM with a beta of 0.59) and a pre-tax Cost of Debt of 5.00%, with an equity weight of 100.00% in the capital structure.

Question 2

Is Neurocrine Biosciences Inc's WACC high or low?

Accepted Answer

Neurocrine Biosciences Inc's WACC of 6.80% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Neurocrine Biosciences Inc's WACC calculated?

Accepted Answer

Neurocrine Biosciences Inc's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 6.80% is derived from the CAPM model using a beta of 0.59. The pre-tax Cost of Debt (Rd) is 5.00%. The capital structure is 100.00% equity and 0.00% debt.

Neurocrine Biosciences Inc (NBIX) — WACC 分析

WACC 构成

解读

Neurocrine Biosciences Inc（NBIX）WACC：6.80%

WACC计算器

Neurocrine Biosciences Inc（NBIX） WACC 解读

NBIX 公司分析

NBIX DCF 估值

继续做同行对比